Clinical Trial Update: Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the addition of pembrolizumab to standard antiretroviral therapy in HIV-positive patients with cancer. The study has completed with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aids-related Non-hodgkin Lymphoma
• Classic Hodgkin Lymphoma
• Hepatocellular Carcinoma
• Melanoma
• Non-small Cell Lung Cancer

Drugs mentioned

• Pembrolizumab (Keytruda) (pembrolizumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: AIDS-Related Non-Hodgkin Lymphoma, Clinical Stage III Cutaneous Melanoma AJCC v8 | Phase 1 | Status: COMPLETED | Results posted: 2024-07-16